OPS
SIOX

Orion Portfolio Solutions’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Orion Portfolio Solutions’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1
Closed – – 2408
2019
Q4 		$0 Buy
+1
New +$6 ﹤0.01% 1993

Other funds holding SIOX

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Orion Portfolio Solutions's SIOX Position: Q1 2020 in Review

Orion Portfolio Solutions sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2020, closing a stake of 1 share.

Orion Portfolio Solutions first reported a position in SIOX in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 42 funds tracked by Wall St. Rank hold SIOX as of Q1 2020.

  • Orion Portfolio Solutions reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Orion Portfolio Solutions sold 1 Sio Gene Therapies Inc. Common Stock share in Q1 2020.
  • Orion Portfolio Solutions first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Orion Portfolio Solutions's Sio Gene Therapies Inc. Common Stock position peaked at $0 in Q4 2019.
  • 42 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2020.

Based on Orion Portfolio Solutions's 13F filing for Q1 2020, filed 15 May 2020.